ROSEMONT, Ill., Feb. 21, 2011 /PRNewswire/ -- LifeWatch AG (SIX Swiss Exchange: LIFE) today announces an initiative with UnitedHealthcare Insurance Company, an affiliate of United-Health Group (NYSE: UNH) that will provide members insured by UnitedHealthcare in-network access to LifeWatch cardiac monitoring services and technologies. LifeWatch is proud to continue our preferred national relationship that began December 1, 2006. The purpose of this initiative is to substantially reduce patient co-pays and deductibles associated with the use of out-of-network cardiac monitoring services provided by other monitoring services.
LifeWatch is the leading independent provider of remote cardiac arrhythmia monitoring devices, home sleep studies and services in the USA, which assist physicians and patients in the early detection and treatment of arrhythmia Obstructive Sleep Apnea (OSA), and can thus prevent heart diseases, stroke, or sudden cardiac death. Millions of people experience arrhythmia and sleep apnea. Typical arrhythmia symptoms include palpitations, rapid heartbeat, dizziness, chest pain and shortness of breath. OSA patients are at risk for a multitude of comorbidities including atrial fibrillation. LifeWatch's services enable a physician who is treating a patient with arrhythmia to prescribe his patient with a range of cardiac monitoring devices that records irregularities in the heart's electrical activity up to a 30-day period. The recorded data is transmitted to the LifeWatch call center, which processes the information and sends a detailed report to the referring physician for interpretation and treatment decisions. Making the LifeWatch services in-network simplifies the process by which a doctor can prescribe them to patients who are insured by UnitedHealthcare.
"LifeWatch is privileged to continue our existing relationship with UnitedHealthcare," said Yacov Geva, LifeWatch president and CEO. "Our agreement strengthens the position of our Cli